Lilly(Eli) & Company
Open
$924.28
Prev. Close
$924.65
High
$924.29
Low
$922.03
Market Snapshot
$804.72B
39.0
11.76
$45.04B
The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees.
Eli Lilly's Q1 earnings forecast indicates significant growth, anticipating $6.66 per share and $17.62 billion revenue, bolstered by sales from Zepbound and Mounjaro.
The company is headquartered in Indianapolis, Indiana and currently employs 50,000 full-time employees.
Recently from Cashu
Eli Lilly Partners with Ro to Enhance Access to Weight Management Solutions with Zepbound KwikPen
Eli Lilly Boosts Access to Weight Management Solutions with New Partnership Eli Lilly and Company strengthens its position in the weight management sector through its strategic partnership with Ro, a…
Eli Lilly Partners with Insilico Medicine for $2.75 Billion AI-Driven Drug Development Deal
Eli Lilly and Company has solidified its position as a leader in pharmaceutical innovation through a transformative partnership with Insilico Medicine. Recently, the U.S. pharmaceutical giant announce…
Eli Lilly Partners with Insilico Medicine for $2.75 Billion AI Drug Development Initiative
Eli Lilly Partners with Insilico Medicine to Transform Drug Development through AI Eli Lilly & Co. embarks on a transformative partnership with Insilico Medicine, marking a strategic $2.75 billion agr…
Eli Lilly's Strategic Response to Health-Conscious Trends in the Food Industry
Eli Lilly & Company's Adaptation to Shifting Consumer Trends in the Food and Beverage Industry In the midst of growing health consciousness among consumers, particularly driven by the rising use of GL…